We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

173 hedge funds and large institutions have $881M invested in Spectrum Pharmaceuticals Inc in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 76 increasing their positions, 38 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 38

16% more capital invested

Capital invested by funds: $757M → $881M (+$123M)

2% less funds holding

Funds holding: 176 → 173 (-3)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

56% less call options, than puts

Call options by funds: $727K | Put options by funds: $1.66M

Holders
173
Holders Change
-3
Holders Change %
-1.7%
% of All Funds
3.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
76
Reduced
38
Closed
22
Calls
$727K
Puts
$1.66M
Net Calls
-$930K
Net Calls Change
-$336K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$9.11M
2
Renaissance Technologies
Renaissance Technologies
New York
+$7.42M
3
SCM
Sio Capital Management
New York
+$5.93M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$5.9M
5
Bank of America
Bank of America
North Carolina
+$5.38M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$26M
2
O
OrbiMed
New York
-$19.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.6M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$8M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$179M +$2.42M +226,089 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$122M +$3.01M +281,134 +3%
Primecap Management
3
Primecap Management
California
$118M +$271K +25,270 +0.2%
State Street
4
State Street
Massachusetts
$58M -$4.64M -433,597 -7%
ACH
5
ArrowMark Colorado Holdings
Colorado
$37.8M +$5.9M +551,105 +18%
Macquarie Group
6
Macquarie Group
Australia
$29.4M +$4.04M +377,480 +16%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$22.8M -$13.6M -1,273,651 -37%
Norges Bank
8
Norges Bank
Norway
$20.8M – – –
AC
9
Armistice Capital
New York
$20.6M +$4.58M +428,000 +29%
Renaissance Technologies
10
Renaissance Technologies
New York
$18.1M +$7.42M +692,582 +69%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$13.7M +$1.3M +121,142 +10%
Northern Trust
12
Northern Trust
Illinois
$13.5M +$95.3K +8,899 +0.7%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$12.7M +$371K +34,599 +3%
CS
14
Candriam SCA
Luxembourg
$11.2M +$697K +65,075 +7%
Millennium Management
15
Millennium Management
New York
$11M +$9.11M +851,103 +489%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$10.8M +$125K +11,660 +1%
Invesco
17
Invesco
Georgia
$10.7M -$1.01M -93,887 -9%
Principal Financial Group
18
Principal Financial Group
Iowa
$9.38M +$259K +24,142 +3%
SIM
19
Sonora Investment Management
Arizona
$7.63M -$142K -13,290 -2%
Bank of America
20
Bank of America
North Carolina
$7.36M +$5.38M +502,703 +271%
Goldman Sachs
21
Goldman Sachs
New York
$7.36M -$755K -70,545 -9%
Wells Fargo
22
Wells Fargo
California
$7.14M -$28.9K -2,702 -0.4%
Ameriprise
23
Ameriprise
Minnesota
$6.42M +$122K +11,415 +2%
Charles Schwab
24
Charles Schwab
California
$6.4M +$450K +41,986 +8%
TA
25
Teachers Advisors
New York
$6.32M +$39.3K +3,671 +0.6%
1
2 3 4 5

SPPI Hedge Fund Activity: Q1 2019 in Review

173 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2019, worth a combined $881M — up 16% from $757M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of SPPI and 19 opened new positions — a net loss of 3 holders — while 38 trimmed existing stakes and 76 added.

The largest buyer was Millennium Management, adding an estimated $9.11M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $26M sold.

  • 173 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2019, down from 176 in Q4 2018.
  • Funds reported $881M of Spectrum Pharmaceuticals Inc stock for Q1 2019, up 16% quarter-over-quarter.
  • 19 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2019 and 22 closed out, a net change of -3 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2019 was Millennium Management, an estimated $9.11M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2019 was Consonance Capital Management, an estimated $26M sold.

Based on aggregated 13F filings for Q1 2019.